Immunohistochemical test for MLH1 and MSH2 is an independent prognostic factor in sporadic colorectal cancer

被引：0
|
作者：
Ohrling, K. [1 ]
Edler, D. [1 ]
Hallstrom, M. [1 ]
Karlberg, M. [1 ]
Ragnhammar, P. [1 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4126
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [22] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [23] MSH2 and MLH1 immunodetection and the prognosis of colon cancer
    Perrin, J
    Monges, G
    Parriaux, D
    Noguchi, T
    Giovannini, MH
    Giovannini, M
    Delpero, JR
    Birnbaum, D
    Monges, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 891 - 895
  • [24] Risks of cancer for MLH1 and MSH2 mutation carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel
    Thibodeau, Stephen N.
    Casey, Graham
    Lindor, Noralane M.
    Gallinger, Steve
    Le Marchand, Loic
    Haile, Robert
    Newcomb, Polly
    Hopper, John L.
    Jenkins, Mark A.
    GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 811 - 811
  • [25] MLH1 and MSH2 expression in pterygia
    Schneider, Barbara G.
    Sahni, Deshdeepak
    Torres, Juan C.
    Dushku, Nicholas
    Reid, Ted W.
    CORNEA, 2007, 26 (04) : 468 - 472
  • [26] Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer
    Casey, G
    Lindor, NM
    Papadopoulos, N
    Thibodeau, SN
    Moskow, J
    Steelman, S
    Buzin, CH
    Sommer, SS
    Collins, CE
    Butz, M
    Aronson, M
    Gallinger, S
    Barker, MA
    Young, JP
    Jass, JR
    Hopper, JL
    Diep, A
    Bapat, B
    Salem, M
    Seminara, D
    Haile, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07): : 799 - 809
  • [27] Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer
    Rey, JM
    Noruzinia, M
    Brouillet, JP
    Sarda, P
    Maudelonde, T
    Pujol, P
    CANCER GENETICS AND CYTOGENETICS, 2004, 155 (02) : 149 - 151
  • [28] Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer
    Renkonen, E
    Zhang, YG
    Lohi, H
    Salovaara, R
    Abdel-Rahman, WM
    Nilbert, M
    Aittomäki, K
    Järvinen, HJ
    Mecklin, JP
    Lindblom, A
    Peltomäki, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3629 - 3637
  • [29] Large genomic aberrations in MSH2 and MLH1 genes are frequent in Chinese colorectal cancer
    Zhu, M
    Li, JT
    Zhang, XM
    Liu, XR
    Friedl, W
    Zhang, YY
    Wu, XL
    Propping, P
    Wang, YP
    CANCER GENETICS AND CYTOGENETICS, 2005, 160 (01) : 61 - 67
  • [30] Genomic rearrangements in MSH2 and MLH1 in Spanish hereditary nonpolyposis colorectal cancer patients
    Castellvi-Bel, S
    Pinol, V
    Castells, A
    Mila, M
    Pique, JM
    GASTROENTEROLOGY, 2004, 126 (04) : A197 - A198
12345